S&P 500   3,312.58 (-0.28%)
DOW   29,061.60 (-0.43%)
QQQ   223.79 (-0.04%)
AAPL   318.04 (+0.11%)
FB   220.05 (-0.57%)
MSFT   166.08 (+0.23%)
GOOGL   1,485.94 (+0.12%)
AMZN   1,879.05 (-0.45%)
CGC   24.28 (+0.66%)
NVDA   251.58 (+0.61%)
BABA   217.84 (-2.04%)
MU   59.39 (+0.37%)
GE   11.72 (+3.08%)
TSLA   566.11 (-0.61%)
AMD   51.22 (-0.41%)
ACB   2.03 (-0.98%)
F   9.04 (-1.31%)
NFLX   343.42 (+5.34%)
DIS   141.61 (-1.67%)
GILD   63.17 (-0.41%)
S&P 500   3,312.58 (-0.28%)
DOW   29,061.60 (-0.43%)
QQQ   223.79 (-0.04%)
AAPL   318.04 (+0.11%)
FB   220.05 (-0.57%)
MSFT   166.08 (+0.23%)
GOOGL   1,485.94 (+0.12%)
AMZN   1,879.05 (-0.45%)
CGC   24.28 (+0.66%)
NVDA   251.58 (+0.61%)
BABA   217.84 (-2.04%)
MU   59.39 (+0.37%)
GE   11.72 (+3.08%)
TSLA   566.11 (-0.61%)
AMD   51.22 (-0.41%)
ACB   2.03 (-0.98%)
F   9.04 (-1.31%)
NFLX   343.42 (+5.34%)
DIS   141.61 (-1.67%)
GILD   63.17 (-0.41%)
S&P 500   3,312.58 (-0.28%)
DOW   29,061.60 (-0.43%)
QQQ   223.79 (-0.04%)
AAPL   318.04 (+0.11%)
FB   220.05 (-0.57%)
MSFT   166.08 (+0.23%)
GOOGL   1,485.94 (+0.12%)
AMZN   1,879.05 (-0.45%)
CGC   24.28 (+0.66%)
NVDA   251.58 (+0.61%)
BABA   217.84 (-2.04%)
MU   59.39 (+0.37%)
GE   11.72 (+3.08%)
TSLA   566.11 (-0.61%)
AMD   51.22 (-0.41%)
ACB   2.03 (-0.98%)
F   9.04 (-1.31%)
NFLX   343.42 (+5.34%)
DIS   141.61 (-1.67%)
GILD   63.17 (-0.41%)
S&P 500   3,312.58 (-0.28%)
DOW   29,061.60 (-0.43%)
QQQ   223.79 (-0.04%)
AAPL   318.04 (+0.11%)
FB   220.05 (-0.57%)
MSFT   166.08 (+0.23%)
GOOGL   1,485.94 (+0.12%)
AMZN   1,879.05 (-0.45%)
CGC   24.28 (+0.66%)
NVDA   251.58 (+0.61%)
BABA   217.84 (-2.04%)
MU   59.39 (+0.37%)
GE   11.72 (+3.08%)
TSLA   566.11 (-0.61%)
AMD   51.22 (-0.41%)
ACB   2.03 (-0.98%)
F   9.04 (-1.31%)
NFLX   343.42 (+5.34%)
DIS   141.61 (-1.67%)
GILD   63.17 (-0.41%)
Log in
(Ad)
If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

NYSE:MKC - MCCORMICK & CO /SH Stock Price, Forecast & News

$171.37
+0.06 (+0.04 %)
(As of 01/23/2020 12:50 PM ET)
Add
Compare
Today's Range
$170.81
Now: $171.37▼
$171.76
50-Day Range
$162.24
MA: $168.84▼
$172.53
52-Week Range
$119.00
Now: $171.37▼
$173.52
Volume11,367 shs
Average Volume646,420 shs
Market Capitalization$22.78 billion
P/E Ratio32.58
Dividend Yield1.45%
Beta0.13
McCormick & Company, Incorporated manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavorful products to the food industry. The company operates in two segments, Consumer and Flavor Solutions. The Consumer segment offers spices, herbs, and seasonings, as well as desserts. This segment markets its products under the McCormick, French, Frank's RedHot, Lawry's, Club House, Gourmet Garden, and OLD BAY brands in the Americas; Ducros, Schwartz, Kamis, and Drogheria & Alimentari, and Vahiné brand names in Europe, the Middle East, and Africa; McCormick and DaQiao brands in China; and McCormick, Aeroplane, and Gourmet Garden brand names in Australia, as well as markets regional and ethnic brands, such as Zatarain's, Stubb's, Thai Kitchen, and Simply Asia. Read More…

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Miscellaneous food preparations & kindred products
Sub-IndustryPackaged Foods & Meats
SectorConsumer Staples
Current SymbolNYSE:MKC
Previous Symbol
CUSIP57978020
CIK63754
Webhttp://www.mccormickcorporation.com/
Phone410-771-7301

Debt

Debt-to-Equity Ratio1.10
Current Ratio0.78
Quick Ratio0.37

Price-To-Earnings

Trailing P/E Ratio32.58
Forward P/E Ratio31.91
P/E Growth4.36

Sales & Book Value

Annual Sales$5.41 billion
Price / Sales4.21
Cash Flow$6.16 per share
Price / Cash Flow27.82
Book Value$24.09 per share
Price / Book7.11

Profitability

EPS (Most Recent Fiscal Year)$4.97
Net Income$933.40 million
Net Margins13.12%
Return on Equity21.63%
Return on Assets7.05%

Miscellaneous

Employees14,400
Outstanding Shares132,910,000
Market Cap$22.78 billion
Next Earnings Date1/28/2020 (Confirmed)
OptionableOptionable

Receive MKC News and Ratings via Email

Sign-up to receive the latest news and ratings for MKC and its competitors with MarketBeat's FREE daily newsletter.

MKC Rates by TradingView

(Ad)

2020 could be a monster year for cannabis stocks, especially with cannabis on many November ballots, and presidential candidates pushing for approval. In our latest special report, we detail five must-own cannabis stocks that could double, even triple your investment over the next year.

MCCORMICK & CO /SH (NYSE:MKC) Frequently Asked Questions

What is MCCORMICK & CO /SH's stock symbol?

MCCORMICK & CO /SH trades on the New York Stock Exchange (NYSE) under the ticker symbol "MKC."

How often does MCCORMICK & CO /SH pay dividends? What is the dividend yield for MCCORMICK & CO /SH?

MCCORMICK & CO /SH declared a quarterly dividend on Tuesday, November 26th. Investors of record on Tuesday, December 31st will be paid a dividend of $0.62 per share on Monday, January 13th. This represents a $2.48 dividend on an annualized basis and a yield of 1.45%. The ex-dividend date is Monday, December 30th. This is an increase from MCCORMICK & CO /SH's previous quarterly dividend of $0.57. View MCCORMICK & CO /SH's Dividend History.

How were MCCORMICK & CO /SH's earnings last quarter?

MCCORMICK & CO /SH NV (NYSE:MKC) released its earnings results on Tuesday, October, 1st. The company reported $1.46 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.29 by $0.17. The company earned $1.33 billion during the quarter, compared to analyst estimates of $1.34 billion. MCCORMICK & CO /SH had a return on equity of 21.63% and a net margin of 13.12%. The firm's quarterly revenue was up .8% compared to the same quarter last year. During the same period in the previous year, the business earned $1.28 EPS. View MCCORMICK & CO /SH's Earnings History.

When is MCCORMICK & CO /SH's next earnings date?

MCCORMICK & CO /SH is scheduled to release their next quarterly earnings announcement on Tuesday, January 28th 2020. View Earnings Estimates for MCCORMICK & CO /SH.

How can I listen to MCCORMICK & CO /SH's earnings call?

MCCORMICK & CO /SH will be holding an earnings conference call on Tuesday, January 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for MKC?

9 brokers have issued 12 month price targets for MCCORMICK & CO /SH's shares. Their forecasts range from $140.00 to $172.00. On average, they anticipate MCCORMICK & CO /SH's share price to reach $156.00 in the next year. This suggests that the stock has a possible downside of 9.0%. View Analyst Price Targets for MCCORMICK & CO /SH.

What is the consensus analysts' recommendation for MCCORMICK & CO /SH?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MCCORMICK & CO /SH in the last year. There are currently 4 sell ratings, 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MCCORMICK & CO /SH.

What are Wall Street analysts saying about MCCORMICK & CO /SH stock?

Here are some recent quotes from research analysts about MCCORMICK & CO /SH stock:
  • 1. According to Zacks Investment Research, "McCormick has outperformed the industry in the past three months, largely driven by its robust-savings initiatives and sales-driving efforts. These factors fueled first-quarter fiscal 2019 results, wherein earnings improved year on year and surpassed the Zacks Consensus Estimate. Also, the top line remained sturdy, gaining from a strong base business as well as new product developments. New launches under the Frank's and French's banners have been yielding results. Notably, the company is on track with new product developments across different categories for fiscal 2019. Also, it is progressing well with augmenting digital marketing efforts. On the flip side, we note that adverse currency fluctuations were a drag on the top and the bottom line during the first quarter. Management expects such headwinds to persist in fiscal 2019." (5/30/2019)
  • 2. Jefferies Financial Group Inc analysts commented, "Results are not directly comparable to our estimates given the adoption of new accounting standards, however, organic sales growth was better than expected, gross margins were flat y/y and EBIT was generally in line. Expectations were high and although 1Q was solid, quality was not high enough, in our view." (3/26/2019)

Has MCCORMICK & CO /SH been receiving favorable news coverage?

Headlines about MKC stock have trended extremely negative this week, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. MCCORMICK & CO /SH earned a news sentiment score of -4.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for MCCORMICK & CO /SH.

Who are some of MCCORMICK & CO /SH's key competitors?

What other stocks do shareholders of MCCORMICK & CO /SH own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MCCORMICK & CO /SH investors own include Johnson & Johnson (JNJ), AT&T (T), Mcdonald's (MCD), Starbucks (SBUX), Home Depot (HD), PepsiCo (PEP), Walt Disney (DIS), Medtronic (MDT), NVIDIA (NVDA) and AbbVie (ABBV).

Who are MCCORMICK & CO /SH's key executives?

MCCORMICK & CO /SH's management team includes the folowing people:
  • Mr. Lawrence E. Kurzius, Chairman, Pres & CEO (Age 61)
  • Mr. Michael R. Smith, Exec. VP & CFO (Age 54)
  • Mr. Jeffery D. Schwartz, VP, Gen. Counsel & Corp. Sec. (Age 49)
  • Mr. Malcolm S. Swift, Pres of Global Flavor Solutions & McCormick International (Age 59)
  • Mr. Brendan F. Foley, Pres of Global Consumer & Americas (Age 53)

Who are MCCORMICK & CO /SH's major shareholders?

MCCORMICK & CO /SH's stock is owned by a number of of institutional and retail investors. Top institutional investors include Huntington National Bank (0.22%), Boston Trust Walden Corp (0.11%), Wendell David Associates Inc. (0.09%), Commerzbank Aktiengesellschaft FI (0.09%), Stock Yards Bank & Trust Co. (0.08%) and Bath Savings Trust Co (0.07%). Company insiders that own MCCORMICK & CO /SH stock include Alan D Wilson, Christina M Mcmullen, Jacques Tapiero, Lawrence Erik Kurzius, Lisa Manzone, Malcolm Swift, Margaret M V Preston, Michael Aaron Conway, Michael D Mangan, Michael R Smith, Nneka Louise Rimmer and Patricia A Little. View Institutional Ownership Trends for MCCORMICK & CO /SH.

Which institutional investors are selling MCCORMICK & CO /SH stock?

MKC stock was sold by a variety of institutional investors in the last quarter, including Ambassador Advisors LLC, State of Alaska Department of Revenue, Sciencast Management LP, Meag Munich Ergo Kapitalanlagegesellschaft MBH, DNB Asset Management AS, Nisa Investment Advisors LLC, Boston Trust Walden Corp and Assenagon Asset Management S.A.. Company insiders that have sold MCCORMICK & CO /SH company stock in the last year include Alan D Wilson, Christina M Mcmullen, Jacques Tapiero, Lisa Manzone, Malcolm Swift, Margaret M V Preston, Michael Aaron Conway, Michael R Smith and Nneka Louise Rimmer. View Insider Buying and Selling for MCCORMICK & CO /SH.

Which institutional investors are buying MCCORMICK & CO /SH stock?

MKC stock was bought by a variety of institutional investors in the last quarter, including Commerzbank Aktiengesellschaft FI, Mainstay Capital Management LLC ADV, Huntington National Bank, AE Wealth Management LLC, Fenimore Asset Management Inc., F3Logic LLC, R. W. Roge & Company Inc. and Livingston Group Asset Management CO operating as Southport Capital Management. View Insider Buying and Selling for MCCORMICK & CO /SH.

How do I buy shares of MCCORMICK & CO /SH?

Shares of MKC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is MCCORMICK & CO /SH's stock price today?

One share of MKC stock can currently be purchased for approximately $171.37.

How big of a company is MCCORMICK & CO /SH?

MCCORMICK & CO /SH has a market capitalization of $22.78 billion and generates $5.41 billion in revenue each year. The company earns $933.40 million in net income (profit) each year or $4.97 on an earnings per share basis. MCCORMICK & CO /SH employs 14,400 workers across the globe.View Additional Information About MCCORMICK & CO /SH.

What is MCCORMICK & CO /SH's official website?

The official website for MCCORMICK & CO /SH is http://www.mccormickcorporation.com/.

How can I contact MCCORMICK & CO /SH?

MCCORMICK & CO /SH's mailing address is 24 Schilling Road Suite 1, Hunt Valley MD, 21031. The company can be reached via phone at 410-771-7301 or via email at [email protected]


MarketBeat Community Rating for MCCORMICK & CO /SH (NYSE MKC)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  419 (Vote Outperform)
Underperform Votes:  517 (Vote Underperform)
Total Votes:  936
MarketBeat's community ratings are surveys of what our community members think about MCCORMICK & CO /SH and other stocks. Vote "Outperform" if you believe MKC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MKC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Featured Article: Learning About the VIX - Volatility Index
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel